Matthew Lennon 

This research aims to identify and evaluate potential treatments for vascular cognitive impairment and dementia, the second most common form of dementia worldwide. There are currently no specific medications available for this condition, leaving people living with dementia with limited options. To address this gap, the project will systematically review all existing clinical trials and treatment studies to assess their effectiveness, ranking therapies based on evidence and impact. Additionally, it will use advanced genetic techniques to discover new drug targets, identifying promising avenues for future treatment development. 

The findings will be compiled into a publicly available database, providing a vital resource for researchers, clinicians, and policymakers looking to advance dementia care. By bridging this critical gap in research, the study aims to pave the way for new, effective treatments that could improve cognitive health, slow disease progression, and enhance the quality of life for people living with dementia and their families.

Dr Matthew Lennon is a conjoint lecturer at the Centre for Healthy Brain Aging at the University of New South Wales (UNSW) and a Neuropsychiatry Registrar working at the Prince of Wales Hospital, Sydney.